StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Tibet Cheezheng Tibetan Medicine Co., Ltd.
Shenzhen Stock Exchange:002287.SZ
Sector
Location
Market Cap
USD 1.70 B
Share Price
USD 3.20
Avg Daily Volume
3,301,088
Change (1 day)
-0.16%
Change (1 year)
21.59%
Change (YTD)
9.16%
Tibet Cheezheng Tibetan Medicine Co., Ltd. EBITDA Margin for the year ending December 31, 2024: 36.07%
Tibet Cheezheng Tibetan Medicine Co., Ltd. EBITDA Margin is 36.07% for the year ending December 31, 2024, a -9.93% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
Tibet Cheezheng Tibetan Medicine Co., Ltd. EBITDA Margin for the year ending December 31, 2023 was 40.05%, a 13.56% change year over year.
-
Tibet Cheezheng Tibetan Medicine Co., Ltd. EBITDA Margin for the year ending December 31, 2022 was 35.27%, a 1.16% change year over year.
-
Tibet Cheezheng Tibetan Medicine Co., Ltd. EBITDA Margin for the year ending December 31, 2021 was 34.86%, a 0.96% change year over year.
-
Tibet Cheezheng Tibetan Medicine Co., Ltd. EBITDA Margin for the year ending December 31, 2020 was 34.53%, a 9.50% change year over year.
Competitors
GE HealthCare Technologies Inc.
USD 75.96
GEHC
-0.28
-0.37%
Laboratory Corporation of America Holdings
USD 243.72
LH
-3.52
-1.42%
Torrent Pharmaceuticals Limited
USD 40.86
TORNTPHARM.NS
+0.16
0.38%
Ascendis Pharma A/S
USD 169.90
ASND
-7.30
-4.12%
Regencell Bioscience Holdings Limited
USD 14.50
RGC
-0.36
-2.42%
Laurus Labs Limited
USD 9.60
LAURUSLABS.NS
+0.05
0.57%
Ipca Laboratories Limited
USD 17.07
IPCALAB.NS
-0.05
-0.30%
ADMA Biologics, Inc.
USD 16.73
ADMA
-0.86
-4.89%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.84
600566.SS
-0.01
-0.25%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.12
002603.SZ
+0.01
0.28%
Pfizer Limited
USD 61.73
PFIZER.NS
-0.55
-0.89%
BGI Genomics Co., Ltd.
USD 7.12
300676.SZ
-0.02
-0.24%
Eris Lifesciences Limited
USD 20.46
ERIS.NS
-0.18
-0.85%
Liaoning Cheng Da Co., Ltd.
USD 1.62
600739.SS
+0.01
0.53%
Hybio Pharmaceutical Co., Ltd.
USD 2.69
300199.SZ
-0.05
-1.72%
Vimian Group AB (publ)
USD 3.84
VIMIAN.ST
-0.61
-13.66%
Harmony Biosciences Holdings, Inc.
USD 35.20
HRMY
-1.23
-3.38%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.24
002020.SZ
-0.01
-0.54%
Arcutis Biotherapeutics, Inc.
USD 14.67
ARQT
-0.81
-5.23%
NovoCure Limited
USD 16.02
NVCR
-0.19
-1.17%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
GE HealthCare Technologies Inc.
USD 75.96
GEHC
-0.28
-0.37%
Laboratory Corporation of America Holdings
USD 243.72
LH
-3.52
-1.42%
Torrent Pharmaceuticals Limited
USD 40.86
TORNTPHARM.NS
+0.16
0.38%
Ascendis Pharma A/S
USD 169.90
ASND
-7.30
-4.12%
Regencell Bioscience Holdings Limited
USD 14.50
RGC
-0.36
-2.42%
Laurus Labs Limited
USD 9.60
LAURUSLABS.NS
+0.05
0.57%
Ipca Laboratories Limited
USD 17.07
IPCALAB.NS
-0.05
-0.30%
ADMA Biologics, Inc.
USD 16.73
ADMA
-0.86
-4.89%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.84
600566.SS
-0.01
-0.25%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.12
002603.SZ
+0.01
0.28%
Pfizer Limited
USD 61.73
PFIZER.NS
-0.55
-0.89%
BGI Genomics Co., Ltd.
USD 7.12
300676.SZ
-0.02
-0.24%
Eris Lifesciences Limited
USD 20.46
ERIS.NS
-0.18
-0.85%
Liaoning Cheng Da Co., Ltd.
USD 1.62
600739.SS
+0.01
0.53%
Hybio Pharmaceutical Co., Ltd.
USD 2.69
300199.SZ
-0.05
-1.72%
Vimian Group AB (publ)
USD 3.84
VIMIAN.ST
-0.61
-13.66%
Harmony Biosciences Holdings, Inc.
USD 35.20
HRMY
-1.23
-3.38%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.24
002020.SZ
-0.01
-0.54%
Arcutis Biotherapeutics, Inc.
USD 14.67
ARQT
-0.81
-5.23%
NovoCure Limited
USD 16.02
NVCR
-0.19
-1.17%